Travel Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Composition (Mono Vaccines v/s Combination Vaccines), By Disease Indication (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others), By Travel Type (Domestic v/s International) and By Region

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027. The market growth can be attributed to the rising incidences of flu and rapid growth in the travel and tourism sector. Travel vaccines, also known as travel immunizations, are vaccine shots that protect travelers from serious illnesses. Vaccines work by exposing the body to germs of the disease it will protect against by enabling the production of antibodies. Besides, increasing awareness regarding the prevention of endemics and transnational infections and stringent advisories and regulations by health authorities to prevent the rise of infectious diseases are some of the factors driving the adoption of travel vaccines. The travel and tourism industry has witnessed a robust growth in recent years with the rise in disposable income of middle-class population across the world. Moreover, increasing trend of exploring different cultures, traditions, spiritualism, rural and ethnic living is propelling the adoption of travel vaccines. The COVID-19 pandemic has led to an increased emphasis on travel vaccines to avoid the spread of infections. As the public is becoming more aware and alert around the spread of infectious diseases, the demand for travel vaccine is expected to proliferate in the coming years. Growth in tourism activities have also led to the booming travel vaccine business for market players.  

Stringent Advisories and Regulations by Health Authorities to Aid the Market Growth

Vaccination for diseases mentioned in the United States Department of Health & Human Services such as chickenpox, cholera, COVID-19, diphtheria, influenza, Hepatitis A, Hepatitis B, pneumococcal, polio, rabies, rotavirus, rubella, shingles, tetanus, typhoid fever, whooping cough, and yellow fever is considered mandatory by some countries. These countries ask for mandatory vaccination proofs documented on an International Certification of Vaccination or Prophylaxis (ICVP) from travelers entering their country. Various countries' governments have implemented policies to prevent traveling citizens from travel-related infections. For instance, the National Health Services (NHS) organizes routine vaccination drives to prevent infectious diseases such as hepatitis A, typhoid, measles, mumps, yellow fever, among others. In addition, travelers coming for Hajj and Umrah in Saudi Arabia from various countries are required to show proof of vaccination for meningitis and seasonal influenza. Major countries such as the United States, Canada, Mexico, United Kingdom, Saudi Arabia, India, China, Japan, and Germany, among others, recommend travelers to be vaccinated for DPT. Increasing regulations for safe traveling are supporting the normalization of travel vaccines among travelers, which is expected to boost the market growth.

High Market Growth Potential in Emerging Nations

Rising personal disposable income of middle-class population in developing nations, owing to improving economic conditions, is increasing demand for travel and tourism. Travel and tourism is rapidly becoming a part of lifestyle for people in developing nations. Besides, growing awareness among population regarding various infections and disease that they could fall prey to while travelling to another country is boosting the travel vaccine market growth. Moreover, governments in developing regions are taking initiatives to create more awareness regarding infectious diseases, which is expected to fuel the growth of travel vaccines in the coming years.


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The global travel vaccine market is segmented by composition, disease indication, travel type, and region. Based on composition, the market is divided into mono vaccines and combination vaccine. Based on disease indication, the market is divided into Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and others. Based on travel type, the market is bifurcated into domestic and international. The market analysis also studies the regional segmentation, divided among North America, Europe, Asia Pacific, Middle east and Africa, South America. The United States is expected to hold a significant share in the global travel vaccine market, owing to rising incidences of infectious diseases and increased spending by population on travelling in the region.

Market Players

Key players operating in the global travel vaccine market are GlaxoSmithKline, plc., Sanofi S.A., Novartis International AG, Merck KGaA, Pfizer Inc., AstraZeneca Plc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, CSL Limited, Johnson & Johnson, among others.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Composition

·         Disease Indication

·         Travel Type

Regional scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; South Korea; Japan; Australia; Singapore; France; Germany; United Kingdom; Italy; Spain; Brazil; Argentina; Colombia; Poland; Denmark; Saudi Arabia; UAE; Turkey; Israel; South Africa

Key companies profiled

GlaxoSmithKline, plc., Sanofi S.A., Novartis International AG, Merck KGaA, Pfizer Inc., AstraZeneca Plc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, CSL Limited, Johnson & Johnson

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, the global travel vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Travel Vaccine Market, By Composition:
    • Mono Vaccines
    • Combination Vaccines
  • Travel Vaccine Market, By Disease Indication:
    • Hepatitis A
    • DPT
    • Yellow Fever
    • Typhoid
    • Hepatitis B
    • Measles and Mumps
    • Rabies
    • Meningococcal
    • Varicella
    • Japanese Encephalitis
    • Others
  • Travel Vaccine Market, By Type:
    • Domestic
    • International
  • Travel Vaccine Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • Singapore
      • South Korea
    • Europe & CIS
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  Saudi Arabia

§  Israel

§  UAE

§  Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global travel vaccine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global travel vaccine market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Travel Vaccine Market

5.    Voice of Customer

5.1.  Travel Vaccination Awareness

5.2.  Travel Vaccination, By Region

5.3.  Travel Vaccination, By Travel Type

6.    Global Travel Vaccine Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Composition (Mono Vaccines v/s Combination Vaccines)

6.2.2.     By Disease Indication (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others)

6.2.3.     By Travel Type (Domestic v/s International)

6.2.4.     By Region

6.3.  Product Market Map

7.    North America Travel Vaccine Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Composition

7.2.2.     By Disease Indication

7.2.3.     By Travel Type

7.2.4.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Travel Vaccine Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Composition

7.3.1.2.2.             By Disease Indication

7.3.1.2.3.             By Travel Type

7.3.2.     Mexico Travel Vaccine Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Composition

7.3.2.2.2.             By Disease Indication

7.3.2.2.3.             By Travel Type

7.3.3.     Canada Travel Vaccine Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Composition

7.3.3.2.2.             By Disease Indication

7.3.3.2.3.             By Travel Type

8.    Europe Travel Vaccine Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Composition

8.2.2.     By Disease Indication

8.2.3.     By Travel Type

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Travel Vaccine Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Composition

8.3.1.2.2.             By Disease Indication

8.3.1.2.3.             By Travel Type

8.3.2.     Germany Travel Vaccine Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Composition

8.3.2.2.2.             By Disease Indication

8.3.2.2.3.             By Travel Type

8.3.3.     United Kingdom Travel Vaccine Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Composition

8.3.3.2.2.             By Disease Indication

8.3.3.2.3.             By Travel Type

8.3.4.     Italy Travel Vaccine Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Composition

8.3.4.2.2.             By Disease Indication

8.3.4.2.3.             By Travel Type

8.3.5.     Spain Travel Vaccine Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Composition

8.3.5.2.2.             By Disease Indication

8.3.5.2.3.             By Travel Type

9.    Asia-Pacific Travel Vaccine Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Composition

9.2.2.     By Disease Indication

9.2.3.     By Travel Type

9.2.4.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Travel Vaccine Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Composition

9.3.1.2.2.             By Disease Indication

9.3.1.2.3.             By Travel Type

9.3.2.     India Travel Vaccine Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Composition

9.3.2.2.2.             By Disease Indication

9.3.2.2.3.             By Travel Type

9.3.3.     South Korea Travel Vaccine Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Composition

9.3.3.2.2.             By Disease Indication

9.3.3.2.3.             By Travel Type

9.3.4.     Japan Travel Vaccine Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Composition

9.3.4.2.2.             By Disease Indication

9.3.4.2.3.             By Travel Type

9.3.5.     Australia Travel Vaccine Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Composition

9.3.5.2.2.             By Disease Indication

9.3.5.2.3.             By Travel Type

9.3.6.     Singapore Travel Vaccine Market Outlook

9.3.6.1.         Market Size & Forecast

9.3.6.1.1.             By Value

9.3.6.2.         Market Share & Forecast

9.3.6.2.1.             By Composition

9.3.6.2.2.             By Disease Indication

9.3.6.2.3.             By Travel Type

10.  South America Travel Vaccine Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Composition

10.2.2.  By Disease Indication

10.2.3.  By Travel Type

10.2.4.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Travel Vaccine Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Composition

10.3.1.2.2.           By Disease Indication

10.3.1.2.3.           By Travel Type

10.3.2.  Argentina Travel Vaccine Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Composition

10.3.2.2.2.           By Disease Indication

10.3.2.2.3.           By Travel Type

10.3.3.  Colombia Travel Vaccine Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Composition

10.3.3.2.2.           By Disease Indication

10.3.3.2.3.           By Travel Type

11.  Middle East and Africa Travel Vaccine Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Composition

11.2.2.  By Disease Indication

11.2.3.  By Travel Type

11.2.4.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Travel Vaccine Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Composition

11.3.1.2.2.           By Disease Indication

11.3.1.2.3.           By Travel Type

11.3.2.  Saudi Arabia Travel Vaccine Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Composition

11.3.2.2.2.           By Disease Indication

11.3.2.2.3.           By Travel Type

11.3.3.  UAE Travel Vaccine Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Composition

11.3.3.2.2.           By Disease Indication

11.3.3.2.3.           By Travel Type

11.3.4.  Israel Travel Vaccine Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Composition

11.3.4.2.2.           By Disease Indication

11.3.4.2.3.           By Travel Type

11.3.5.  Turkey Travel Vaccine Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Composition

11.3.5.2.2.           By Disease Indication

11.3.5.2.3.           By Travel Type

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape (Inclusive of SWOT Analysis of Players Profiled)

14.1.              GlaxoSmithKline, plc.

14.2.              Sanofi S.A.

14.3.              Novartis International AG

14.4.              Merck KGaA

14.5.              Pfizer Inc.

14.6.              AstraZeneca Plc.

14.7.              Abbott Laboratories, Inc.

14.8.              F. Hoffmann-La Roche AG

14.9.              CSL Limited

14.10.            Johnson & Johnson

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

North America is expected to hold the dominant share in the global travel vaccine market during the forecast period.

down-arrow

Increased spending on travel activities and rising awareness regarding infectious disorders are expected to drive the growth of the global travel vaccine market.

down-arrow

Based on disease indication, the Hepatitis A segment is expected to dominate global travel vaccine market in the forecast period.

down-arrow

GlaxoSmithKline, plc., Sanofi S.A., Novartis International AG, Merck KGaA, Pfizer Inc., AstraZeneca Plc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, CSL Limited, Johnson & Johnson are major players operating in the global travel vaccine market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Travel Vaccine Market Projected to be Dominated by the Hepatitis A Segment Through 2027

Aug, 2022

Rising awareness towards transnational infections and increasing inclination towards leisure travelling are contributing to the growth of the global travel vaccine market.

Why Choose Us